skip to content

Institute of Metabolic Science

Metabolic Research Laboratories
 

Research Interests:

Understanding the Impact of Early Life Nutritional Exposures on Long-term Cardiometabolic Health: 

The major focus of our research is to understand the mechanisms by which sub-optimal early life nutrition impacts on long-term risk of type 2 diabetes, obesity, cardiovascular disease and premature death. A large number of epidemiological studies suggest that such relationships exist- for example of children born from obese pregnancies or those exposed to under-nutrition in utero- however the molecular mechanisms mediating such relationships are not well understood. Our goal is to define these mechanisms and to use this understanding to develop rational prevention and intervention strategies. Our most recent work has focussed on applying our mechanistic understanding to address the most appropriate interventions during obese, diabetic pregnancy for maximum short- and long- term benefit to both mother and child.  

Maternal-Fetal Communication during Health and Complicated Pregnancy:

The placenta is an endocrine organ that acts as a key interface between mother and fetus with the capacity to influence immediate and long-term maternal and offspring metabolism. We have shown that its structure and function is modulated in obese diabetic pregnancies and responsive to both pharmacological (e.g. metformin) and lifestyle (e.g. physical activity) interventions during pregnancy. Our current studies are utilising mouse models and isolated human trophoblasts to identify secreted placental proteins (some of which are in extracellular vesicles) that traffic to maternal and fetal organs to influence their function and to establish how this is modified during complicated pregnancies.  

Interventions During Obese Glucose Intolerant Pregnancy to Improve Maternal and Offspring Cardio-Metabolic Health:

Pregnancy is a window of opportunity to improve the health of at least two generation. However, it is also a complex challenge with short and long- term effects on two individuals – mother and child to be considered. We have developed models of both pharmocological (administration of metformin) and lifestyle (peri-gestational exercise) interventions during obese pregnancy. These intervention studies are providing vital clues as to the mechanism underlying the programming of offspring cardio-metabolic disorders in maternal obesity. Our findings from studies with metformin administration during pregnancy have highlighted beneficial immediate effects on maternal physiology but identified some potential negative effects on maternal metabolism. On-going studies are exploring the mechanisms underlying these effects.  

miRNAs as mediators of early life nutrition on long term health: 

We have a strong interest in defining the role of miRNAs as potential mediators of the effects of early life nutrition on gene expression and organ function. We use a range of molecular techniques to determine whether microRNAs in tissues such as the brain, heart, liver and adipose tissue may be epigenetic regulators that are sensitive to programming by the nutritional environment associated with obese diabetic pregnancies and thus contribute to the dysfunction observed in these tissues. Some of our current work is focussed on understanding if alteration in miRNA content of extracellular vesicles is one mechanism by which sub-optimal early life nutrition impacts on inter-organ communication. 

Early Life Nutrition, Oxidative Stress and Accelerated Ageing: 

One of the striking observations in offspring exposed to sub-optimal early life nutrition has been that life span can be increased or decreased by restricting growth either during suckling or fetal life, respectively. This led us to hypothesise that accelerated cellular ageing may be one mechanism by which sub-optimal early life nutrition increases risk of traditionally adult-onset diseases such as type 2 diabetes and cardiovascular disease. We subsequently showed that programmed differences in lifespan are associated with differences in telomere length, mitochondrial function and oxidative damage in a number of organs. We are currently exploring if accelerated ageing is a common mechanism linking the effects of a range of sub-optimal nutritional exposures on long-term cardiometabolic health.  


Group Members 

Miss Andreea Cristian, PhD Student - adc90 at medschl.cam.ac.uk​   

Mrs Claire Custance, Senior Research Technician - cg358 at cam.ac.uk    

Dr Adriana Paz Cordova, Post-doctoral Research Fellow - ap2427 at medschl.cam.ac.uk    

Dr Denise Fernandez-Twinn, Senior Research Associate - df220 at cam.ac.uk  

Pedro Moniz Gomes, MPhil Student - pm861 at cam.ac.uk 

Keyshla Negron, NIH Oxcam PhD student joint with Dr Laura Dearden (IMS) and Prof Carlos Guardia (NIH) - kn447 at cam.ac.uk

Dr Lais Vales Mennetti, Postdoctoral Research Associate - lv325 at medschl.cam.ac.uk 

Mrs Elaine Withers, Personal Assistant - ew439 at medschl.cam.ac.uk 

Kwun Kiu (Will) Wong, Senior Research Technician/Lab Manager - kkw28 at medschl.cam.ac.uk 


Funding 

British Heart Foundation 

Loke Centre for Trophoblast Research 

Medical Research Council 

Publications

Key publications: 

Dearden L, Furigo IC, Pantaleao LC, Wong LWP, Fernandez-Twinn DS, de Almeida-Faria J, Kentistou KA, Carreira MV, Bidault G, Vidal-Puig A, Ong KK, Perry JRB, Donato J & Ozanne SE (2024) Maternal obesity increases hypothalamic miR-505-5p expression in mouse offspring leading to altered fatty acid sensing and increased intake of high-fat food PLoS Biology 22(6):e3002641 doi.org/10.1371/journal.pbio.3002641  

Pantaleao LC, Loche E, Fernandez-Twinn DS, Dearden L, Cordova-Casanova A, Osmond C, Salonen M, Kajantie E, Nu Y, de Almeida-Faria J, Thackray BD, Mikkola T, Giussani DA, Murray AJ, Bushell M, Eriksson JG & Ozanne SE (2024) Programming of cardiac metabolism by miR-15b-5p, a miRNA released in cardiac extracellular vesicles following ischaemia reperfusion injury. Molecular Metabolism 80:101875 doi.org/10.1016%2Fj.molmet.2024.101875  

Dearden L & Ozanne SE (2023) Considerations for designing and analysing inter-generational studies in rodents. Nat Metab 5(1): 1-4 doi.org/10.1038/s42255-022-00721-7  

Schoonejans JM, Blackmore HL, Ashmore TJ, Pantaleão LC, Pisani LP, Dearden L, Tadross JA, Aiken CE, Fernandez-Twinn DS & Ozanne SE (2022) Sex specific effects of maternal metformin intervention during glucose-intolerant obese pregnancy on body composition and metabolic health in aged mouse offspring. Diabetologia 65: 2132-2145 doi.org/10.1007/s00125-022-05789-0  

Pantaleao LC, Inzani I, Furse S, Loche E, Hufnagel A, Ashmore T, Blackmore HL, Jenkins B, Carpenter AAM, Wilczynska A, Bushell M, Koulman A, Fernandez-Twinn DS & Ozanne SE (2022) Maternal diet-induced obesity during pregnancy alters lipid supply to mouse E18.5 fetuses and changes the cardiac tissue lipidome in a sex-dependent manner. Elife 11: e69078 PMID: 35025731​ 

Sandovici I, Fernandez-Twinn DS, Hufnagel A, Constancia M & Ozanne SE (2022) Sex differences in the intergenerational inheritance of metabolic traits. Nature Metabolism 4: 507-523 PMID: 35637347 

Hufnagel A, Fernandez-Twinn DS, Blackmore HL, Ashmore TJ, Heaton RA, Jenkins B, Koulman A, Hargreaves IP, Aiken CE, Ozanne SE. Maternal but not fetoplacental health can be improved by metformin in a murine diet-induced model of maternal obesity and glucose intolerance. J Physiol. 2021 Sep 10. doi: 10.1113/JP281902. PMID: 34505282 

de Almeida-Faria J, Duque-Guimarães DE, Ong TP, Pantaleão LC, Carpenter AA, Loche E, Kusinski LC, Ashmore TJ, Antrobus R, Bushell M, Fernandez-Twinn DS, Ozanne SE. Maternal obesity during pregnancy leads to adipose tissue ER stress in mice via miR-126-mediated reduction in Lunapark. Diabetologia. 2021 Apr;64(4):890-902. doi: 10.1007/s00125-020-05357-4. Epub 2021 Jan 27. PMID: 33501603 PMCID: PMC7940301     

Dearden L, Buller S, Furigo IC, Fernandez-Twinn DS, Ozanne SE. Maternal obesity causes fetal hypothalamic insulin resistance and disrupts development of hypothalamic feeding pathways. Mol Metab. 2020 Sep 9;42:101079. doi: 10.1016/j.molmet.2020.101079. PMID: 32919096. PMCID: PMC7549144 

Tarry-Adkins JL, Aiken CE, Ozanne SE. Comparative impact of pharmacological treatments for gestational diabetes on neonatal anthropometry independent of maternal glycaemic control: a systematic review and meta-analysis. PLoS Medicine  2020 May 22; 17(5): e1003126.doi: 10.1371/journal.pmed.1003126. PMID: 32442232. PMCID: PMC7244100 

Nicholas LM, Nagao M, Kusinski LC, Fernandez-Twinn DS, Eliasson L, Ozanne SE. (2019) Exposure to maternal obesity programs sex differences in pancreatic islets of the offspring in mice. Diabetologia. Nov 26. doi: 10.1007/s00125-019-05037-y PMID: 31773193. PMCID: PMC6946752 

Tarry-Adkins JL, Aiken CE, Ozanne SE (2019) Neonatal, infant and childhood growth following metformin versus insulin treatment for gestational diabetes: a systematic review and meta-analysis PLoS Med. Aug 6;16(8):e1002848. doi: 10.1371/journal.pmed.1002848. PMID: 31386659. PMCID: PMC6684046 

Professor of Developmental Endocrinology
Head of Department of Clinical Biochemistry, University of Cambridge
Director IMS-MRL
photo of sue ozanne

Contact Details

Email address: 
Classifications: